Kursaklioglu, H <br/><br/>
Spironolactone does not prevent restenosis after coronary stenting in humans.  [electronic resource] 

 -  Annals of the Academy of Medicine, Singapore  Nov 2004 
 - 769-74 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0304-4602 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Coronary Restenosis--epidemiology<br/>Double-Blind Method<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Male<br/>Middle Aged<br/>Spironolactone--therapeutic use<br/>Treatment Failure